Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses.
about
Trial Watch: Adoptive cell transfer for oncological indicationsTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyTrial watch: IDO inhibitors in cancer therapyTrial watch: Dendritic cell-based anticancer therapyTrial Watch-Oncolytic viruses and cancer therapyTrial Watch: Proteasomal inhibitors for anticancer therapyFirst oncolytic virus approved for melanoma immunotherapy.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.The oncolytic virus, pelareorep, as a novel anticancer agent: a review.Trial Watch: Radioimmunotherapy for oncological indications.Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.
P2860
Q26785545-F07DB7C6-4D16-4FF1-A24D-FE8FDA88AC0BQ27004011-F8291D04-E1E3-406F-9F03-25FF00F78D4AQ27006866-9EB732F7-AE10-4BA7-B39F-BEACC4283D73Q27024047-9FD5510D-598D-45E8-90E0-02B4DDB7F746Q28072347-75E8413C-292C-4469-94E8-CC6EFCFD7C38Q28082910-530E491F-3D74-477E-8AE2-40DA448EB43CQ36597333-C1C70B6C-6D0A-4019-99EE-578EE598A04DQ37079141-7C901435-5A46-4A93-8A21-C7B25882C0DDQ38360781-0AF2206F-7384-4DD5-A8AF-B376F77FFD27Q43104064-56D58032-7CEB-4607-AD4A-C046C2A9BFA3Q51795706-20F45C67-FBBA-4527-B8EA-40C48B093413
P2860
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Two is better than one: Comple ...... te antitumor immune responses.
@en
Two is better than one: Comple ...... te antitumor immune responses.
@nl
type
label
Two is better than one: Comple ...... te antitumor immune responses.
@en
Two is better than one: Comple ...... te antitumor immune responses.
@nl
prefLabel
Two is better than one: Comple ...... te antitumor immune responses.
@en
Two is better than one: Comple ...... te antitumor immune responses.
@nl
P2093
P2860
P356
P1433
P1476
Two is better than one: Comple ...... te antitumor immune responses.
@en
P2093
Derek Clements
Patrick Wk Lee
Shashi A Gujar
P2860
P304
P356
10.4161/ONCI.27622
P577
2014-01-06T00:00:00Z